PERRY SIGMA II

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2012-05-01 for PERRY SIGMA II manufactured by Perry Baromedical.

Event Text Entries

[2687650] During the ascent of our last hyperbaric o2 treatment, it was noted that the chamber was ascending slower than normal. The dive was completed with no ill effects to the pt. After the dive was completed, the chamber mfr (perry baromedical) was called and told of the problem. Their tech, (b)(4) called us back and instructed us on how to adjust the needle valve control knot to increase the rate of ascent of the chamber. The rate adjustment was tested during 5 more timed dives of the chamber. The next morning ((b)(6) 2012) the chamber was tested again with compression and decompression rates falling within the mfrs spec's. (b)(4) (perry's tech) was on the phone during the testing and approved the use of the chamber. (b)(6), was informed of the situation with the chamber. (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5025262
MDR Report Key2561447
Date Received2012-05-01
Date of Report2012-04-25
Date of Event2012-04-12
Date Added to Maude2012-05-08
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationRESPIRATORY THERAPIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NamePERRY SIGMA II
Generic NameHYPERBARIC OXYGEN CHAMBER
Product CodeCBF
Date Received2012-05-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Sequence No1
Device Event Key0
ManufacturerPERRY BAROMEDICAL
Manufacturer Address3660 INTERSTATE PKWY RIVIERA BEACH FL 33404 US 33404


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2012-05-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.